LASK ALISA enters COLLPLANT BIOTECHNOLOGIES LTD with 10K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030193
10K
Baseline shares
100% direct
10K
Direct ownership
1 position
47K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Restricted Share Units
DirectShares owned10K
Total
10K direct10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Restricted Share Units | 10K | Direct |
| Total | 10K | 10K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
47K
Shares owned
N/A
Exercise price
6.39
Expiration
—
Exercise window
—
Total
Underlying
47K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 6.39 | — | — | 47K | N/A |
| Total | 47K | 0.00 | ||||